EU starts building trial data portal
This article was originally published in Scrip
Preparations for the implementation of the EU Clinical Trials Regulation are intensifying, with the European Medicines Agency (EMA) and member states now thrashing out the technicalities of the new portal and database system through which companies will have to submit all their trial data.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
As arguments rage over whether the UK regulator has rushed its assessment of the Pfizer/BioNTech vaccine, the European Medicines Agency explains why its conditional marketing authorization approach is taking a little longer.
The UK has used a special legislative process to temporarily authorize the use of the BNT-162b2 vaccine, with the first 800,000 shots expected to be delivered within days.